SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Peter Singleton who wrote (3942)3/18/1998 3:26:00 PM
From: Steve Fancy  Read Replies (1) | Respond to of 6136
 
Monthly IMS scrip data reported as being in-line...

Total 42,132
New 15,495
Refills 26,637

PaineWebbers notes indicated that Month-to-Month were down, but Monday's strong data shows demand is picking up. They also pointed out Crixivan continuing to lose market share.

I wonder if we wait till earnings to hear how non-US revenues are proceeding.

sf



To: Peter Singleton who wrote (3942)3/18/1998 11:13:00 PM
From: billkirn  Read Replies (1) | Respond to of 6136
 
Peter: Good observations, thanks. I hope Roche will start
pushing Viracept+Saquinavir. This seems like an important economic direction for them to replace the Saquinavir + Norvir combo.
They must be doing some serious verification for this combo, since they benefit directly.
Bill


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News